JP2022055977A - Inhibitor for new coronavirus growth - Google Patents

Inhibitor for new coronavirus growth Download PDF

Info

Publication number
JP2022055977A
JP2022055977A JP2020163719A JP2020163719A JP2022055977A JP 2022055977 A JP2022055977 A JP 2022055977A JP 2020163719 A JP2020163719 A JP 2020163719A JP 2020163719 A JP2020163719 A JP 2020163719A JP 2022055977 A JP2022055977 A JP 2022055977A
Authority
JP
Japan
Prior art keywords
new coronavirus
coronavirus
inhibitor
growth
minutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020163719A
Other languages
Japanese (ja)
Inventor
国昭 根路銘
Kuniaki Nejime
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nerome Inst Of Biological Resources
Nerome Institute Of Biological Resources
Original Assignee
Nerome Inst Of Biological Resources
Nerome Institute Of Biological Resources
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nerome Inst Of Biological Resources, Nerome Institute Of Biological Resources filed Critical Nerome Inst Of Biological Resources
Priority to JP2020163719A priority Critical patent/JP2022055977A/en
Publication of JP2022055977A publication Critical patent/JP2022055977A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

To provide an inhibitor for new coronavirus growth, which is capable of strongly inactivating new coronavirus.SOLUTION: Provided is an inhibitor for new coronavirus growth, comprising an extract of a Meliaceae plant. The inhibitor is prepared by, for example, adding 9 volumes of distilled water to 1 volume of Meliaceae leaves (Leaf of Melia azedarach L.), subjecting the mixture to heat treatment at 115°C for 35 minutes, grinding the mixture with a food processor and centrifuging it at 7, 500 x g for 13 minutes, and adding an equal amount of alcohol to the supernatant, letting the supernatant stand overnight, filtering the supernatant after centrifugation at 7, 500 x g for 13 minutes, and adding phytoncide to this at a rate of 2.5% to prevent precipitation.SELECTED DRAWING: Figure 1

Description

特許法第30条第2項適用申請有り 令和2年2月14日 ウェブサイト https://gendai.ismedia.jp/articles/-/70375 https://gendai.ismedia.jp/articles/-/70375?page=2 https://gendai.ismedia.jp/articles/-/70375?page=3 https://gendai.ismedia.jp/articles/-/70375?page=4 にて公開There is an application for application of Article 30, Paragraph 2 of the Patent Act. February 14, 2nd year of Reiwa Website https: // gendai. ismedia. jp / articles // 70375 https: // gendai. ismedia. jp / articles /-/ 70375? page = 2 https: // gendai. ismedia. jp / articles /-/ 70375? page = 3 https: // gendai. ismedia. jp / articles /-/ 70375? Published on page = 4

本発明は、新型コロナウイルス増殖抑制剤に関する。 The present invention relates to a new type coronavirus growth inhibitor.

呼吸器感染症を代表するインフルエンザには、その予防策としてワクチンが開発され、今日まで日本をはじめとする先進国で幅広く使用されてきた。同時に、ワクチンと平行して有用な消毒剤の探索研究も進められ、トリインフルエンザのH5N1ウイルスに対する物理学的物質(非特許文献1、2)やイオディン系統の化学薬剤(非特許文献3、4、5)等もインフルエンザ消毒液として報告されてきた。しかしながら、本格的な消毒剤としては利用されていない。他方、パラミクソウイルス科を代表するパラインフルエンザやRSウイルスについてのワクチンは無く、加えて有効な消毒液もまだ開発されていない。これらの呼吸器ウイルス以上に、現在問題になっているのが新型コロナウイルスであるが、米国やヨーロッパそして日本でも本格的なワクチン開発が進んでいる。しかしながら、新型コロナウイルスについての有効な消毒液に至っては、科学的に検証された消毒液は、およそ500編の最新の論文を調べても、今日まで報告されていない。 Vaccines have been developed as a preventive measure against influenza, which represents respiratory infections, and have been widely used in developed countries including Japan to this day. At the same time, research on exploration of useful disinfectants in parallel with vaccines has been carried out, and physical substances against the H5N1 virus of avian influenza (Non-Patent Documents 1 and 2) and Iodine-based chemical agents (Non-Patent Documents 3 and 4, 5) etc. have also been reported as influenza disinfectants. However, it has not been used as a full-fledged disinfectant. On the other hand, there is no vaccine against parainfluenza and RS virus, which are representative of the paramyxoviridae family, and no effective antiseptic solution has been developed yet. More than these respiratory viruses, the new coronavirus is currently a problem, but full-scale vaccine development is underway in the United States, Europe, and Japan. However, as for the effective disinfectant solution for the new coronavirus, scientifically verified disinfectant solution has not been reported to date even after examining about 500 latest papers.

このような現状を振り返ってみる時、ワクチンの使用や抗ウイルス剤による治療は、あくまでも感染性ウイルスに対する守りの理想的な対策である。感染症への対策は、守りと攻撃による調和の取れた対策が重要である。このように考えてみると、やはり攻撃の主軸である武器が必要になってくるのは必然の論理である。そこで本発明者は、生物資源の中からウイルスを効果的に殺傷する消毒液を探索する過程で、インフルエンザウイルスを強力に殺傷するセンダン葉抽出液を発見した(非特許文献6)。しかしながら、センダン葉抽出液が、新型コロナウイルスに有効であるか否かは知られていない。 Looking back on this situation, the use of vaccines and treatment with antiviral agents are ideal measures to protect against infectious viruses. As for measures against infectious diseases, it is important to take harmonious measures by defense and attack. Thinking in this way, it is an inevitable logic that weapons, which are the main axis of attack, are needed. Therefore, the present inventor discovered a Sendan leaf extract that strongly kills influenza virus in the process of searching for a disinfectant that effectively kills the virus from biological resources (Non-Patent Document 6). However, it is not known whether the Chinaberry leaf extract is effective against the new coronavirus.

Wanaratana S, Tantilertcharoen R, Sasipreeyajan J, Pakpinyo S (2010) The inactivation of avian influenza virus subtype H5N1 isolated from chckens in Thailand by chemical and physical treatments. Vet. Microbiol 140:43-48Wanaratana S, Tantilertcharoen R, Sasipreeyajan J, Pakpinyo S (2010) The inactivation of avian influenza virus subtype H5N1 isolated from chckens in Thailand by chemical and physical treatments. Vet. Microbiol 140: 43-48 Shahid MA, Abubakar M, Hameed S, Hassan S (2009) Avian influenza virus (H5N1); effects of physico-chemical factors on its survival. Virol J 6:38Shahid MA, Abubakar M, Hameed S, Hassan S (2009) Avian influenza virus (H5N1); effects of physico-chemical factors on its survival. Virol J 6:38 Sabracos L, Romanou S, Dontas I et al(2007) The in vitro effective antiviral action of povidone-iodine (PVP-I) may also have therapeutice potential by its intravenous administration diluted with Ringer's solution. Me. Hypotheses 68:272-274Sabracos L, Romanou S, Dontas I et al (2007) The in vitro effective antiviral action of povidone-iodine (PVP-I) may also have therapeutice potential by its intravenous administration diluted with Ringer's solution. Me. Hypotheses 68: 272-274 Hidari KIPJ, Tsujii E, Hiroi J et al(2004) In vitro and in vivo inhibitory effects of disodium cromoglycate in influenza virus infection. Biol Pharm Bull 27:825-830Hidari KIPJ, Tsujii E, Hiroi J et al (2004) In vitro and in vivo inhibitory effects of disodium cromoglycate in influenza virus infection. Biol Pharm Bull 27: 825-830 Zhao L, Huo CH, Shen LR et al(2010) Chemical constituents of plants from the genus Melia. Cehm Biodivers 7:839-859Zhao L, Huo CH, Shen LR et al (2010) Chemical constituents of plants from the genus Melia. Cehm Biodivers 7: 839-859 Nerome K, Shimizu F, Zukeran S, Igarashi Y, Kuroda K, Sugita S, Shibata T, Ito Y, Nerome R (2018). Functional growth inhibition of influenza A and B viruses by liquid and powder components of leaves from the subtropical plant Melia Azedarach L. Arch. Virol. 163: 2099-2109Nerome K, Shimizu F, Zukeran S, Igarashi Y, Kuroda K, Sugita S, Shibata T, Ito Y, Nerome R (2018). Functional growth inhibition of influenza A and B viruses by liquid and powder components of leaves from the subtropical plant Melia Azedarach L. Arch. Virol. 163: 2099-2109

本発明者は、このセンダン液が新型コロナウイルスにも効くのかについて調べた。その結果、予想外にも、センダン抽出液が新型コロナウイルスを強く不活化できることを見出し、本発明を完成した。 The present inventor investigated whether this Sendan solution is also effective against the new coronavirus. As a result, it was unexpectedly found that the Sendan extract can strongly inactivate the new coronavirus, and the present invention was completed.

すなわち、本発明は、以下に関する。
[1] センダン科植物の抽出物を含む、新型コロナウイルス増殖抑制剤、
[2] センダン科植物が、センダン(Melia azedarach)である、[1]に記載の新型コロナウイルス増殖抑制剤、
[3] センダン科植物が、センダン科植物の葉である、[2]に記載の新型コロナウイルス増殖抑制剤。
That is, the present invention relates to the following.
[1] A new type coronavirus growth inhibitor containing an extract of a mahogany plant,
[2] The new coronavirus growth inhibitor according to [1], wherein the plant of the family Meliaceae is Sendan (Melia azedarach).
[3] The new type coronavirus growth inhibitor according to [2], wherein the mahogany plant is a leaf of the mahogany plant.

センダン科(Meliaceae)は、双子葉綱ムクロジ目に属する植物の科で、熱帯から亜熱帯、温帯にかけて、46属700種あまりが分布している。日本では温暖な地域にセンダンが自生しているほか、中国原産のチャンチン(香椿)が庭木として栽培されている。 The family Meliaceae is a family of plants belonging to the order Sapindales of the dicotyledonous family, and about 700 species of 46 genera are distributed from tropical to subtropical and temperate zones. In Japan, Chinaberry grows naturally in warm regions, and Chinese native toona sinensis is cultivated as a garden tree.

センダン(Melia azedarach L.)は、センダン科センダン属に分類される落葉高木の1種である。薬用植物の一つとしても知られ、果実はしもやけ、樹皮は虫下し、葉は虫除けにするなど、薬用に重宝された。ヒマラヤ、中国、台湾、朝鮮半島南部と日本の熱帯・亜熱帯域に自生する。日本では、本州(伊豆半島以西)、伊豆諸島、四国、九州、沖縄に分布する。 Chinaberry (Melia azedarach L.) is a species of deciduous tree that belongs to the genus Melia of the family Melia. Also known as one of the medicinal plants, it was useful for medicinal purposes, such as chilblains for fruits, insect repellent for bark, and insect repellent for leaves. It grows naturally in the Himalayas, China, Taiwan, the southern part of the Korean Peninsula, and the tropical and subtropical regions of Japan. In Japan, it is distributed in Honshu (west of the Izu Peninsula), the Izu Islands, Shikoku, Kyushu, and Okinawa.

センダン科植物をそのままか又は乾燥した後、微細に粉砕して粉末、顆粒などの固形状にした乾燥粉末を水で抽出し水性抽出物として用いることができる。抽出に使用する水の量は任意とすることができるが、5分の1~10倍量で用いるのがよく、特に約9倍量で用いるのが好ましい。加水後に加熱処理をすることができる。加熱処理は、たとえば、115℃、35分間の条件であることができる。抽出は、特に、ミキサーなどで攪拌しながら粉砕して行うことができる。ミキサーでの撹拌時間は、当業者が適宜定めることができる。撹拌後、この粉砕液を遠心分離して上清を回収して抽出液を得ることができる。遠心分離の際の回転数及び時間は、当業者が適宜定めることができるが、例えば、7,500xgで13分間であってもよい。或いは、必要に応じて 10,000xgで60分でも良い。得られた上清に、等量のアルコールを添加し、さらに一晩放置することができる。抽出液は、そのまま用いてもよいが、凍結保存し、使用前に濾過滅菌フィルターで濾過滅菌してもよい。また、沈殿防止のためにフィトンチットを添加することができる。 The mahogany plant can be used as an aqueous extract by extracting the dry powder as it is or after drying it into a solid state such as powder or granules with water. The amount of water used for extraction can be arbitrary, but it is preferable to use it in an amount of 1/5 to 10 times, and particularly preferably in an amount of about 9 times. Heat treatment can be performed after water addition. The heat treatment can be, for example, at 115 ° C. for 35 minutes. Extraction can be carried out by pulverizing with stirring, in particular, with a mixer or the like. The stirring time in the mixer can be appropriately determined by those skilled in the art. After stirring, the pulverized solution can be centrifuged to collect the supernatant to obtain an extract. The number of revolutions and the time for centrifugation can be appropriately determined by those skilled in the art, and may be, for example, 7,500 xg for 13 minutes. Alternatively, if necessary, 10,000 xg may be used for 60 minutes. An equal amount of alcohol can be added to the obtained supernatant and left overnight. The extract may be used as it is, or it may be cryopreserved and sterilized by filtration with a filtration sterilization filter before use. In addition, phytoncide can be added to prevent precipitation.

新型コロナウイルスとは、SARSコロナウイルス2(severe acute respiratory syndrome coronavirus 2、略称: SARS-CoV-2)のことであり、新型コロナウイルス感染症(COVID-19)の原因となる、SARS関連コロナウイルス(SARSr-CoV)に属するコロナウイルスである。日本の国家機関は新型コロナウイルスと呼んでおり、新型コロナと省略される場合もある。 The new coronavirus is SARS coronavirus 2 (severe acute respiratory syndrome 2, abbreviated as SARS-CoV-2), which is a cause of the new coronavirus infection (COVID-19). It is a coronavirus belonging to (SARSr-CoV). The Japanese state institution calls it the new coronavirus, which is sometimes abbreviated as the new corona.

SARSコロナウイルス2は、ゲノムとして一本鎖プラス鎖RNAを持つ、コロナウイルスに属している。この仲間は哺乳類や鳥類に感染する非常に多数の種を含むが、人に感染症を引き起こすものだけでも、重篤な肺炎の原因となるSARSコロナウイルス (SARS-CoV) やMERSコロナウイルス (MERS-CoV)、季節性の風邪を引き起こすヒトコロナウイルス229E (HCoV-229) やHCoV-OC43、HCoV-NL63、HCoV-HKU1などがある。SARS-CoV-2は、2019年にヒトに対して病原性を有する7番目のコロナウイルスとして出現したものである。 SARS coronavirus 2 belongs to the coronavirus, which has a single-strand plus-strand RNA as a genome. This family includes a large number of species that infect mammals and birds, but the SARS coronavirus (SARS-CoV) and MERS coronavirus (MERS) that cause severe pneumonia, even those that cause infectious diseases in humans, are included. -CoV), human coronavirus 229E (HCoV-229) that causes seasonal colds, HCoV-OC43, HCoV-NL63, HCoV-HKU1 and the like. SARS-CoV-2 emerged in 2019 as the seventh coronavirus pathogenic to humans.

ウイルス粒子(ビリオン)は、50~200nm(ナノメートル)ほどの大きさである。一般的なコロナウイルスと同様に、S(スパイク)タンパク質、N(ヌクレオカプシド)タンパク質、M(膜)タンパク質、E(エンベロープ)タンパク質として知られる4つのたんぱく質と、RNAにより構成されている。このうち、Nタンパク質がRNAと結合してヌクレオカプシドを形成し、脂質と結合したS、EおよびMタンパク質がその周りを取り囲んでエンベロープを形成する。エンベロープの最も外側に位置するSタンパク質は、細胞表面のACE2受容体に結合して細胞への感染を可能とする。ヒトへの感染にACE2受容体を利用する点はSARSコロナウイルス(SARS-CoV)と共通しており、DPP-4受容体を利用するMERSコロナウイルス(MERS-CoV)や、アミノペプチダーゼN(APN)を利用するヒトコロナウイルス229Eとは異なる。ウイルスゲノムは29,903塩基で、一本鎖プラス鎖RNAウイルスである。 Virus particles (virions) have a size of about 50 to 200 nm (nanometers). Like a common coronavirus, it is composed of four proteins known as S (spike) protein, N (nucleocapsid) protein, M (membrane) protein, and E (envelope) protein, and RNA. Of these, N proteins bind to RNA to form nucleocapsids, and S, E and M proteins bound to lipids surround them to form an envelope. The outermost S protein in the envelope binds to the ACE2 receptor on the cell surface, allowing infection of the cell. The point that ACE2 receptor is used for human infection is common with SARS coronavirus (SARS-CoV), MERS coronavirus (MERS-CoV) that uses DPP-4 receptor, and aminopeptidase N (APN). ) Is different from human coronavirus 229E. The viral genome is 29,903 bases and is a single-strand plus-strand RNA virus.

本発明ではTCID50値(50%組織培養細胞感染価)を用いて新型コロナウイルスに対する増殖抑制効果を評価した。 In the present invention, the growth inhibitory effect on the new coronavirus was evaluated using the TCID50 value (50% tissue culture cell infectious titer).

本発明の新型コロナウイルス増殖抑制剤は、各種の物質、例えば、賦形剤、希釈剤、崩壊剤、結合剤、被覆剤、潤滑剤、滑走剤、滑沢剤、風味剤、甘味剤、可溶化剤等を補助剤として含むことができる。具体的には、炭酸マグネシウム、二酸化チタン、ラクトース、マンニトール及びその他の糖類、タルク、ミルク蛋白、ゼラチン、澱粉、セルロース及びその誘導体、動物及び植物油、ポリエチレングリコール、グリセロールなどがあげられる。 The novel coronavirus growth inhibitor of the present invention includes various substances such as excipients, diluents, disintegrants, binders, coating agents, lubricants, lubricants, lubricants, flavoring agents, sweeteners, and the like. A solubilizer or the like can be included as an auxiliary agent. Specific examples thereof include magnesium carbonate, titanium dioxide, lactose, mannitol and other sugars, talc, milk protein, gelatin, starch, cellulose and derivatives thereof, animal and vegetable oils, polyethylene glycol, glycerol and the like.

センダン科植物の抽出物の希釈倍率は、使用目的・条件等に応じて当業者が適宜定めることができるが、例えば、2倍~20000倍であることが好ましく、より好ましくは10倍~5000倍、より好ましくは500倍~2000倍であってもよい。 The dilution ratio of the extract of the family Meliaceae can be appropriately determined by those skilled in the art according to the purpose of use, conditions, etc., but is preferably 2 to 20000 times, more preferably 10 to 5000 times, for example. , More preferably 500 to 2000 times.

本発明の新型コロナウイルス増殖抑制剤は、噴霧してもよいが、これらに限定されるものではない。 The novel coronavirus growth inhibitor of the present invention may be sprayed, but is not limited thereto.

噴霧量は、使用目的・条件等により当業者が適宜定めることができるが、例えば、噴霧する面積を基準として、0.001mL/m2~50mL/m2であることが好ましく、より好ましくは0.01mL/m2~20mL/m2、より好ましくは0.1mL/m2~10mL/m2である。 The amount of spray can be appropriately determined by those skilled in the art depending on the purpose of use, conditions, etc., but for example, it is preferably 0.001 mL / m 2 to 50 mL / m 2 based on the sprayed area, and more preferably 0. It is 0.01 mL / m 2 to 20 mL / m 2 , more preferably 0.1 mL / m 2 to 10 mL / m 2 .

本発明の新型コロナウイルス増殖抑制剤は、新型コロナウイルスの増殖を抑制することができる。 The new coronavirus growth inhibitor of the present invention can suppress the growth of the new coronavirus.

センダン液の新型コロナウイルスに対する増殖阻害効果である。 X軸は、感染実験で攻撃に用いたウイルス量の組織培養細胞に対する指数値であり、y軸は、その時のセンダン液のlog10の希釈倍数である。It is a growth inhibitory effect of Sendan's solution against the new coronavirus. The X-axis is an exponential value of the amount of virus used for the attack in the infection experiment with respect to the tissue culture cells, and the y-axis is the dilution factor of log 10 of the Sendan solution at that time.

以下に、本発明を実施例により詳細に説明する。 Hereinafter, the present invention will be described in detail with reference to Examples.

材料及び方法
センダン葉(Leaf of Melia azedarach L.)1容に対し9容の蒸留水を加えて115℃35分間加熱処理し、次いでフードプロセッサで粉砕して7,500xg、13分で遠心、上清に等量のアルコールを加えた。これを一夜静置後、7,500xg、13分で遠心後の上清を濾過し、これに沈殿防止のために2.5%の割合でフィトンチットを加えた。
Materials and Methods 9 volumes of distilled water was added to 1 volume of Leaf of Melia azedarach L. and heat-treated at 115 ° C. for 35 minutes, then ground with a food processor and centrifuged at 7,500 xg for 13 minutes. An equal amount of alcohol was added to Qing. After allowing this to stand overnight, the supernatant after centrifugation was filtered at 7,500 xg for 13 minutes, and phytoncide was added to the supernatant at a ratio of 2.5% to prevent precipitation.

細胞とウイルス
新型コロナウイルスのSARS-COV-2については岡山理科大学獣医学部の森川博士に実験を委託した。その時使用したVero E6/TMPRSS-2細胞は10%牛胎児血清(FCS)を含むDMEM培地で培養した。
Cells and Viruses The new coronavirus SARS-COV-2 was commissioned to Dr. Morikawa of the Faculty of Veterinary Medicine, Okayama University of Science. The Vero E6 / TMPRSS-2 cells used at that time were cultured in DMEM medium containing 10% fetal bovine serum (FCS).

センダン液とウイルスの反応
DMEMと1%FCSの培地で希釈した各センダン希釈液10容とSARS-COV-2 1容を混合し、25℃で1時間反応させた。対照はDMEMと1%FCSを混合した培地10容に1容のウイルス液を混合し室温で1時間反応させた。上に述べた混合反応液を10倍段階希釈して96Wellプレートに1Well当たり40μl接種し、4日後にCPE出現を観察して50%TCID値を求めた。TCID50とは50%の組織培養細胞感染価のことである。
Reaction of Sendan solution and virus 10 volumes of each Sendan diluted solution diluted with DMEM and 1% FCS medium and 1 volume of SARS-COV-2 were mixed and reacted at 25 ° C. for 1 hour. As a control, 1 volume of virus solution was mixed with 10 volumes of medium in which DMEM and 1% FCS were mixed, and the mixture was reacted at room temperature for 1 hour. The mixed reaction solution described above was diluted 10-fold and inoculated into a 96-well plate at 40 μl per well, and after 4 days, the appearance of CPE was observed to obtain a 50% TCID value. TCID50 is a tissue culture cell infectious titer of 50%.

結果及び考察
図1に実験結果を示した。新型コロナウイルスのSARS-COV-2をVero細胞に感染させた時のウイルス量を5.11×10とした時、センダンの抽出液を100倍に希釈して処理すると、培養液中のウイルスは1×10以下で、ウイルス増殖は100%阻止されていたことが明らかにされた。当然のことながら10倍希釈でもCPEはマイナスで、ウイルス増殖は1×10以下であったと推定された。同じセンダン液でインフルエンザウイルスA/PR-8/34(H1N1)ウイルスに対するプラーク阻害率が10-4であったことから、新型コロナに対する増殖阻害率は10-4の希釈で5.11×10の50%のコロナウイルスを死滅させていたのではないかと推定された。
Results and Discussion Figure 1 shows the experimental results. When the viral load of the new coronavirus SARS-COV-2 infecting Vero cells was 5.11 × 106 , the virus in the culture solution was treated by diluting the Sendan extract 100 times. Was 1 × 101 or less, and it was revealed that virus growth was 100% blocked. As a matter of course, it was estimated that the CPE was negative even at the 10-fold dilution, and the virus growth was 1 × 101 or less. Since the plaque inhibition rate for influenza virus A / PR-8 / 34 (H1N1) virus was 10 -4 in the same Sendan solution, the growth inhibition rate for the new corona was 5.11 × 10 6 with a dilution of 10 -4 . It was estimated that 50% of the coronaviruses were killed.

脂質成分を外膜とするエンベロープウイルス、例えばインフルエンザウイルス、ハシカ・ムンプス等のパラミクソウイルスは、概してアルコール消毒が効かなりことが知られている。インフルエンザウイルスをアルコール濃度 10%、20%、40%、50%で処理してもウイルスを不活化することができない。加えて、目下日本でも幅広く利用されている次亜塩素酸水は細胞毒性が強く、その10倍希釈液で全ての細胞が死滅してしまうが、肝心のウイルス殺傷効果はセンダンの1000分の1程度であった。 It is known that alcohol disinfection is generally effective for enveloped viruses having a lipid component as an outer membrane, such as influenza virus and paramyxovirus such as Hashika mumps. Even if the influenza virus is treated with alcohol concentrations of 10%, 20%, 40%, and 50%, the virus cannot be inactivated. In addition, hypochlorite water, which is widely used in Japan at present, has strong cytotoxicity, and all cells are killed by its 10-fold diluted solution, but the essential virus-killing effect is 1/1000 of that of Sendan. It was about.

このことから、センダン抽出液は新型コロナウイルスにも強い殺傷効果を持ち、有望な消毒液になるものと考えた。新型コロナウイルスの大きな特徴は無症状感染者が多く、その上、軽い上気道患者も多く、その間に多くの人に感染を広げてしまうことで、そうしたウイルス伝播者を阻止するためには、ワクチンよりも消毒液が現実的に重要である。その意味でこの度の発見は、ワクチンの開発に相当する価値があると考える。 From this, it was considered that the Sendan extract has a strong killing effect on the new coronavirus and is a promising disinfectant. A major feature of the new coronavirus is that there are many asymptomatic infected people, and there are also many patients with mild upper respiratory tract, and in the meantime, the infection spreads to many people. The disinfectant is more practically important than the disinfectant. In that sense, we believe that this discovery is worth the development of a vaccine.

本発明の新型コロナウイルス増殖抑制剤は、環境中の新型コロナウイルスの増殖を抑制することができる。本発明のCOVID-19の増殖抑制剤は、空間および物体表面の清浄化のための、噴霧剤(スプレーなど)、塗布剤(クリームなど)、洗浄剤(液状、半固体、個体の石鹸など)の成分として利用することができる。 The new coronavirus growth inhibitor of the present invention can suppress the growth of the new coronavirus in the environment. The growth inhibitor of COVID-19 of the present invention is a spray (spray, etc.), a coating agent (cream, etc.), a cleaning agent (liquid, semi-solid, solid soap, etc.) for cleaning spaces and object surfaces. It can be used as a component of.

Claims (3)

センダン科植物の抽出物を含む、新型コロナウイルス増殖抑制剤。 A new type of coronavirus growth inhibitor containing an extract of a mahogany plant. センダン科植物が、センダン(Melia azedarach)である、請求項1に記載の新型コロナウイルス増殖抑制剤。 The novel coronavirus growth inhibitor according to claim 1, wherein the plant of the family Meliaceae is Sendan (Melia azedarach). センダン科植物が、センダン科植物の葉である、請求項2に記載の新型コロナウイルス増殖抑制剤。 The new coronavirus growth inhibitor according to claim 2, wherein the mahogany plant is a leaf of the mahogany plant.
JP2020163719A 2020-09-29 2020-09-29 Inhibitor for new coronavirus growth Pending JP2022055977A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020163719A JP2022055977A (en) 2020-09-29 2020-09-29 Inhibitor for new coronavirus growth

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2020163719A JP2022055977A (en) 2020-09-29 2020-09-29 Inhibitor for new coronavirus growth

Publications (1)

Publication Number Publication Date
JP2022055977A true JP2022055977A (en) 2022-04-08

Family

ID=80998425

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020163719A Pending JP2022055977A (en) 2020-09-29 2020-09-29 Inhibitor for new coronavirus growth

Country Status (1)

Country Link
JP (1) JP2022055977A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023200289A1 (en) * 2022-04-14 2023-10-19 한국 한의학 연구원 Composition for prevention, amelioration or treatment of coronavirus infection comprising medicinal herb extract as active ingredient

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023200289A1 (en) * 2022-04-14 2023-10-19 한국 한의학 연구원 Composition for prevention, amelioration or treatment of coronavirus infection comprising medicinal herb extract as active ingredient
KR20230147388A (en) * 2022-04-14 2023-10-23 한국 한의학 연구원 Composition for preventing, ameliorating or treating coronavirus infectious disease comprising herbal medicine extract as effective component

Similar Documents

Publication Publication Date Title
Droebner et al. CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice
US8765138B2 (en) Antiviral and antibacterial activity from medicinal mushrooms
Shibnev et al. Antiviral activity of Inonotus obliquus fungus extract towards infection caused by hepatitis C virus in cell cultures
US20060171958A1 (en) Antiviral activity from medicinal mushrooms
US20140105928A1 (en) Antiviral and antibacterial activity from medicinal mushrooms
EP2314303B1 (en) Composition for prevention of influenza viral infection comprising sumac extract, air filter comprising the same and air cleaning device comprising the filter
JP5571577B2 (en) Textile products for antiviral hygiene against envelope viruses belonging to the genus influenza A
CN110917196A (en) Chloroquine antibacterial disinfectant and application thereof
CN1897958B (en) Antiviral preparations obtained from a natural cinnamon extract
Ashraf et al. Phytochemical composition and potent biological activities of ficus benjamina VAR. comosa leaves extract
JP2022055977A (en) Inhibitor for new coronavirus growth
Nerome et al. Functional growth inhibition of influenza A and B viruses by liquid and powder components of leaves from the subtropical plant Melia azedarach L.
Anyanwu et al. Antiviral activities of Cucumis metuliferus fruits alkaloids on Infectious Bursal Disease Virus (IBDV)
JP5618228B2 (en) Antiviral composition and use thereof
JPWO2010005010A1 (en) Anti-influenza virus agent, anti-RS virus agent and anti-immunodeficiency virus agent
JP4307459B2 (en) Influenza preventive / therapeutic agent
US20230151302A1 (en) Cationic surfactants, in particular ethyl lauroyl arginate LAE, for treating or preventing infections and contaminations with Coronavirus
Pu et al. Anti-influenza A virus effect of Hypericum perforatum L. extract
Shaukat et al. Comparative efficacy of various antiviral agents against avian influenza virus (Type H7N3/Pakistan/2003)
Nikomtat et al. Inhibition of Inula cappa (Ham. ex D. Don) DC. extracts on herpes simplex virus infection in vitro
JP5173813B2 (en) Drugs for the prevention and treatment of influenza
CN101262873B (en) Use of cistus incanus extracts for the preparation of a medicament for the prevention and/or treatment of influenza
CN111803418B (en) Antiviral composition and application thereof in children daily necessities
Boseila et al. Evaluation of the antiviral activity of sage leaves (Salvia officinalis) extract against foot-and-mouth disease virus.
Nazir et al. Evaluation of in ovo antiviral activities of medicinal flowers against Newcastle disease virus and Avian Influenza virus.

Legal Events

Date Code Title Description
A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20201005